1. Home
  2. APRE vs FEBO Comparison

APRE vs FEBO Comparison

Compare APRE & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • FEBO
  • Stock Information
  • Founded
  • APRE 2006
  • FEBO 1993
  • Country
  • APRE United States
  • FEBO Hong Kong
  • Employees
  • APRE N/A
  • FEBO N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • FEBO
  • Sector
  • APRE Health Care
  • FEBO
  • Exchange
  • APRE Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • APRE 8.3M
  • FEBO 8.3M
  • IPO Year
  • APRE 2019
  • FEBO 2023
  • Fundamental
  • Price
  • APRE $1.51
  • FEBO N/A
  • Analyst Decision
  • APRE Strong Buy
  • FEBO
  • Analyst Count
  • APRE 1
  • FEBO 0
  • Target Price
  • APRE $20.00
  • FEBO N/A
  • AVG Volume (30 Days)
  • APRE 50.3K
  • FEBO 46.2K
  • Earning Date
  • APRE 11-06-2025
  • FEBO 10-28-2025
  • Dividend Yield
  • APRE N/A
  • FEBO N/A
  • EPS Growth
  • APRE N/A
  • FEBO N/A
  • EPS
  • APRE N/A
  • FEBO N/A
  • Revenue
  • APRE $841,012.00
  • FEBO $17,110,653.00
  • Revenue This Year
  • APRE N/A
  • FEBO N/A
  • Revenue Next Year
  • APRE N/A
  • FEBO N/A
  • P/E Ratio
  • APRE N/A
  • FEBO N/A
  • Revenue Growth
  • APRE N/A
  • FEBO 11.58
  • 52 Week Low
  • APRE $1.37
  • FEBO $0.61
  • 52 Week High
  • APRE $5.01
  • FEBO $5.20
  • Technical
  • Relative Strength Index (RSI)
  • APRE 51.04
  • FEBO 45.49
  • Support Level
  • APRE $1.40
  • FEBO $0.67
  • Resistance Level
  • APRE $1.53
  • FEBO $0.78
  • Average True Range (ATR)
  • APRE 0.08
  • FEBO 0.08
  • MACD
  • APRE 0.01
  • FEBO 0.00
  • Stochastic Oscillator
  • APRE 67.77
  • FEBO 41.05

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: